文献速递胸部肿瘤消化系统肿瘤头颈与中枢神经肿瘤

2011至2020年河北省恶性肿瘤疾病负担分析

[Cancer burden in Hebei Province from 2011 to 2020].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2025-01-01

基于河北省38个肿瘤登记处2011—2020年数据,分析恶性肿瘤发病与死亡趋势。2020年粗发病率229.36/10万,粗死亡率146.38/10万;世标发病率从2011年206.61/10万降至2020年143.74/10万(AAPC -4.2%,P<0.001),世标死亡率从147.69/10万降至84.79/10万(AAPC -5.7%,P<0.001)。

要点

  • 2020年河北省估计新发恶性肿瘤约17.16万例,死亡约10.89万例。
  • 2011—2020年世标发病率和死亡率均呈下降趋势,AAPC分别为-4.2%和-5.7%。
  • 甲状腺癌发病率上升较快,AAPC为9.7%。

核心结论

  • 2011—2020年河北省肿瘤登记地区恶性肿瘤世标发病率和死亡率呈下降趋势,但总体负担仍处于较高水平。

研究设计与样本

  • 收集河北省38个肿瘤登记处2011—2020年恶性肿瘤发病死亡数据,计算不同地区、性别、年龄别发病(死亡)率和标化发病(死亡)率,并分析变化趋势。

主要发现

  • 2020年河北省肿瘤登记地区恶性肿瘤粗发病率为229.36/10万,中标发病率为147.06/10万,估计全省新发病例约17.16万例。
  • 2020年恶性肿瘤粗死亡率为146.38/10万,中标死亡率为85.33/10万,估计全省死亡病例约10.89万例。
  • 84%的恶性肿瘤发生在50岁及以上人群。
  • 世标发病率从2011年206.61/10万下降至2020年143.74/10万,AAPC为-4.2%(P<0.001)。
  • 世标死亡率从2011年147.69/10万下降至2020年84.79/10万,AAPC为-5.7%(P<0.001)。

关键数值与推荐

  • 肺癌、食管癌、胃癌、肝癌、结直肠癌世标发病率AAPC依次为-4.0%、-12.3%、-9.4%、-6.0%、-1.6%(均P<0.001)。
  • 肺癌、食管癌、胃癌、肝癌、结直肠癌世标死亡率AAPC依次为-4.9%、-11.3%、-8.5%、-5.7%、-3.3%(均P<0.001)。
  • 甲状腺癌发病率AAPC为9.7%(P<0.001)。
  • 女性乳腺癌和男性前列腺癌世标发病率相对稳定。

临床怎么用

  • 原文结论提出需加强肿瘤防控,提高全社会防癌意识,推进三级预防理念以降低河北省恶性肿瘤负担。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To understand the burden of cancer disease in Hebei Province in recent years and to analyze the change trend of cancer in Hebei Province from 2011 to 2020. Methods: The incidence and death data of cancer were collected from 38 cancer registries in Hebei Province during 2011-2020. The incidence (mortality) rate, standardized incidence (mortality) rate and composition ratio of each region, sex, and age were calculated respectively, and the incidence and death of major cancers in our province were summarized. The age-standardized morbidity (mortality) rates of China and the world population were calculated using the 2000 China standard population composition and Segi's world population composition respectively. Trend analysis of morbidity and mortality was performed and average annual percentage change (AAPC) was calculated. Results: In 2020, the crude cancer incidence rate and the age-standardized morbidity rate of China was 229.36/100 000 and 147.06/100 000, respectively. An estimated 171 600 new cases were reported in the province. The crude cancer mortality rate and the age-standardized mortality rates of China was 146.38/100 000 and 85.33/100 000. The estimated number of deaths in the province is 108 900. In the cancer registration areas of Hebei Province, 84% of all cancer patients occurred in people 50 years of age and older. From 2011 to 2020, the incidence and mortality of cancer in Hebei Province showed a decreasing trend. The AAPC was -4.2% (P<0.001), which decreased from 206.61/100 000 in 2011 to 143.74/100 000 in 2020. The world standard mortality rate of cancer was 147.69/100 000 in 2011, and decreased to 84.79/100 000 in 2020. The AAPC was -5.7% (P<0.001). The world-standard incidence and mortality of lung cancer, esophageal cancer, gastric cancer, liver cancer and colorectal cancer decreased from 2011 to 2020. The AAPCs of the world-standard incidence were -4.0%, -12.3%, -9.4%, -6.0% and -1.6%, respectively. The AAPCs of the world-standard mortality were -4.9%, -11.3%, -8.5%, -5.7% and -3.3%, which were statistically significant. The incidence of thyroid cancer increased rapidly, the AAPC of which was 9.7% (P<0.001). The rates of female breast cancer and male prostate cancer in Hebei Province were stable. Conclusions: The world-standard incidence and mortality of cancer in Hebei Provincial cancer registries areas show a downward trend from 2011 to 2020. However, the cancer incidence and mortality in Hebei Province are still at high levels. It's necessary to strengthen cancer prevention and control in Hebei Province, improve the awareness of cancer prevention and control in the whole society, and promote the concept of tertiary cancer prevention to reduce the cancer burden in Hebei Province. 目的: 为了解河北省恶性肿瘤疾病负担情况,对河北省肿瘤登地区2011—2020年恶性肿瘤发病和死亡变化趋势进行分析。 方法: 收集河北省38个肿瘤登记处2011—2020年恶性肿瘤发病死亡数据,计算不同地区、性别、年龄别发病(死亡)率和标化发病(死亡)率,并报告河北省主要恶性肿瘤的发病和死亡情况。采用2000年中国标准人口构成和Segi's世界人口构成分别计算中国和世界人口年龄标化发病(死亡)率(简称中标率和世标率)。对发病率和死亡率进行趋势分析,计算平均年度变化百分比(AAPC)。 结果: 2020年,河北省肿瘤登记地区恶性肿瘤粗发病率为229.36/10万,中标发病率为147.06/10万,估计全省新发病例约17.16万例;恶性肿瘤粗死亡率为146.38/10万,中标率为85.33/10万,估计全省死亡病例约10.89万例。84%的恶性肿瘤发生在50岁及以上人群。2011—2020年,河北省肿瘤登记地区恶性肿瘤世标发病率和死亡率呈下降趋势。世标发病率从2011年的206.61/10万下降至2020年的143.74/10万,AAPC为-4.2%(P<0.001);世标死亡率从2011年的147.69/10万下降至2020年的84.79/10万,AAPC为-5.7%(P<0.001)。2011—2020年河北省肿瘤登记地区肺癌、食管癌、胃癌、肝癌、结直肠癌世标发病率和世标死亡率均呈下降趋势,世标发病率的AAPC依次为-4.0%、-12.3%、-9.4%、-6.0%、-1.6%,世标死亡率的AAPC依次为-4.9%、-11.3%、-8.5%、-5.7%、-3.3%(均P<0.001)。甲状腺癌发病率上升较快,AAPC为9.7%(P<0.001)。女性乳腺癌和男性前列腺癌世标发病率相对稳定。 结论: 2011—2020年河北省肿瘤登记地区恶性肿瘤世标发病率和死亡率呈下降趋势,但总体负担仍处于较高水平,需加强肿瘤防控,进一步降低河北省恶性肿瘤负担。.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Li DJ, Liang D, Shi J, et al. [Cancer burden in Hebei Province from 2011 to 2020]. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 40268548. doi:10.3760/cma.j.cn112152-20240110-00017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。